Cargando…
Retracing Circulating Tumour Cells for Biomarker Characterization after Enumeration
BACKGROUND: Retracing and biomarker characterization of individual circulating tumour cells (CTCs) may potentially contribute to personalized metastatic cancer therapy. This is relevant when a biopsy of the metastasis is complicated or impossible to acquire. METHODS: A novel disc format was used to...
Autores principales: | Frandsen, Anders S., Fabisiewicz, Anna, Jagiello-Gruszfeld, Agnieszka, Haugaard, Anastasiya S., Petersen, Louise Munkhaus, Albrektsen, Katrine Brandt, Nejlund, Sarah, Smith, Julie, Stender, Henrik, Hillig, Thore, Sölétormos, György |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572983/ https://www.ncbi.nlm.nih.gov/pubmed/28936241 http://dx.doi.org/10.5772/60995 |
Ejemplares similares
-
In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods
por: Hillig, Thore, et al.
Publicado: (2015) -
In vitro validation of an ultra-sensitive scanning fluorescence microscope for analysis of Circulating Tumor Cells
por: Hillig, Thore, et al.
Publicado: (2014) -
Assessing HER2 amplification by IHC, FISH, and real-time polymerase chain reaction analysis (real-time PCR) following LCM in formalin-fixed paraffin embedded tissue from 40 women with ovarian cancer
por: Hillig, Thore, et al.
Publicado: (2012) -
Retracing the evolutionary emergence of thymopoiesis
por: Swann, Jeremy B., et al.
Publicado: (2020) -
Postoperative hyperpyrexia: Retracing malignant hyperthermia
por: Gupta, Devendra, et al.
Publicado: (2012)